Healthcare & Life Sciences
The IBA Healthcare & Life Sciences Law Committee, has just issued its e-bulletin on legal and ethical issues around Covid-19 and vaccines.
With an introduction co-authored by Alison Choy Flannigan from Hall & Wilcox and our partner Cécile Théard-Jallu, Vice-Chair of the Committee, the e-bulletin gathers 20 articles from leading health and life sciences players from across Europe, Central and South America and the Asia Pacific region.
Among theses articles covering issues such as equity of access, consent, intellectual property, product distribution, immunization, records, passports, privacy, adverse events and liability, check out notably:
Throughout his career and after over 30 years as at Sanofi becoming the Global Senior Vice-President of Prospective and Strategic Initiatives, Jean-Claude Muller has gained impressive experience allowing him to share views on key evolutions and stakes of the pharmaceutical and life sciences industry and makes some observations on life after the Covid-19 crisis… Read more
Associate The production and distribution of Covid-19 vaccines are considered to be too slow in many countries, including France, and opening intellectual property rights might be observed as a solution to spread access to vaccines… Read more
Since the sanitary crisis started, the French Government has issued many orders meant to restrict the circulation of French citizens both within the national territory and outside its borders. The vaccine passport newly contributes to legal and ethical debates in France and in the EU on how much freedoms can be limited for sake of securing health… Read more
Find out more articles from this e-bulletin here.
These articles first appeared on the website of the Healthcare and Life Sciences Law Committee of the Legal Practice Division of the International Bar Association, and are reproduced by kind permission of the International Bar Association, London, UK. © International Bar Association.